Physician profile
Dina S Prus
NPI 1871565887
$2,182.54
in general payments reported to CMS, 2019-2025
24 companies · $83.84 in 2025
The $83.84 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,039 · 2020: $644 · 2021: $238 · 2022: $69.17 · 2023: $74.18 · 2024: $34.64 · 2025: $83.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $420.11 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $325.65 | 2019-2024 | Enhertu |
| Merck Sharp & Dohme LLC | $234.77 | 2019-2021 | |
| Lilly USA, LLC | $183.73 | 2019-2023 | Mounjaro, Trulicity |
| Amarin Pharma, INC. | $179.35 | 2019-2021 | |
| Medtronic, INC. | $130.88 | 2021-2025 | Minimed 780g |
| Gilead Sciences, INC. | $104.32 | 2019-2020 | |
| Glaxosmithkline, LLC. | $82.45 | 2020-2023 | Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $73.22 | 2019-2020 | |
| Amgen INC. | $70.49 | 2019-2020 | |
| Dexcom, INC. | $58.30 | 2021-2023 | Dexcom G6 Transmitter |
| Insulet Corporation | $55.18 | 2019 | |
| Janssen Pharmaceuticals, INC | $54.43 | 2019-2020 | |
| Medtronic Minimed, INC. | $40.79 | 2019 | |
| Abbvie INC. | $26.74 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.25 | 2019-2021 | |
| Horizon Therapeutics Plc | $23.70 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $14.80 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.44 | 2021 | |
| Corcept Therapeutics | $13.68 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.56 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.50 | 2019 | |
| Cequr Corporation | $12.20 | 2023 | Cequr Simplicity |
| Senseonics, Incorporated | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dina Prus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.